(Q45877161)

17 December 2017

title

Two-in-one: combined targeted chemo and gene therapy for tumor suppression and prevention of metastases (English)

1 reference

17 December 2017

0 references

5

Tamara Minko

1 reference

17 December 2017

author name string

Min Zhang

1

1 reference

17 December 2017

Olga B Garbuzenko

2

1 reference

17 December 2017

Kenneth R Reuhl

3

1 reference

17 December 2017

Lorna Rodriguez-Rodriguez

4

1 reference

17 December 2017

publication date

1 February 2012

1 reference

17 December 2017

published in

Nanomedicine

1 reference

17 December 2017

volume

7

1 reference

17 December 2017

issue

2

1 reference

17 December 2017

page(s)

185-197

1 reference

17 December 2017

Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it?

cites work

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.131

Ovarian cancer survival population differences: a "high resolution study" comparing Philippine residents, and Filipino-Americans and Caucasians living in the US

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.131

The value of ovarian cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.131

The risk of death by age, sex, and smoking status in the United States: putting health risks in context

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.131

Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.131

Cancer metastasis: characterization and identification of the behavior of metastatic tumor cells and the cell adhesion molecules, including carbohydrates

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.131

The prosurvival activity of ascites against TRAIL is associated with a shorter disease-free interval in patients with ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.131

c-Met overexpression contributes to the acquired apoptotic resistance of nonadherent ovarian cancer cells through a cross talk mediated by phosphatidylinositol 3-kinase and extracellular signal-regulated kinase 1/2.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.131

Overexpression of human sperm protein 17 increases migration and decreases the chemosensitivity of human epithelial ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.131

Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.131

The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.131

Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.131

Phase II trial of weekly nanoparticle albumin-bound paclitaxel with carboplatin and trastuzumab as first-line therapy for women with HER2-overexpressing metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.131

Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.131

Reversal of multidrug resistance by co-delivery of tariquidar (XR9576) and paclitaxel using long-circulating liposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.131

Nanoparticulate delivery system targeted to tumor neovasculature for combined anticancer and antiangiogenesis therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.131

Molecular targeting of drug delivery systems to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.131

Simultaneous modulation of multidrug resistance and antiapoptotic cellular defense by MDR1 and BCL-2 targeted antisense oligonucleotides enhances the anticancer efficacy of doxorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.131

In vitro and in vivo intracellular liposomal delivery of antisense oligonucleotides and anticancer drug

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.131

Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.131

Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.131

Targeted proapoptotic anticancer drug delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.131

Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.131

Novel polymeric prodrug with multivalent components for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.131

Receptor targeted polymers, dendrimers, liposomes: which nanocarrier is the most efficient for tumor-specific treatment and imaging?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.131

JNK1 as a molecular target to limit cellular mortality under hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.131

Non-viral systemic delivery of siRNA or antisense oligonucleotides targeted to Jun N-terminal kinase 1 prevents cellular hypoxic damage

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.131

The antioxidant tempamine: in vitro antitumor and neuroprotective effects and optimization of liposomal encapsulation and release.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.131

Molecular targeting of BCL2 and BCLXL proteins by synthetic BCL2 homology 3 domain peptide enhances the efficacy of chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.131

Efficacy of the chemotherapeutic action of HPMA copolymer-bound doxorubicin in a solid tumor model of ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.131

Nonviral nanoscale-based delivery of antisense oligonucleotides targeted to hypoxia-inducible factor 1 alpha enhances the efficacy of chemotherapy in drug-resistant tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.131

Multifunctional tumor-targeted polymer-peptide-drug delivery system for treatment of primary and metastatic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.131

Inhibition of adenoma progression to adenocarcinoma in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model in A/J mice by tea polyphenols and caffeine.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.131

Serous psammocarcinoma of the ovary: CT and MR findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.131

Calcifications in mucinous and serous cystic ovarian tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.131

Albendazole: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation in OVCAR-3 tumor-bearing nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.131

Antitumor activity and molecular effects of the novel heat shock protein 90 inhibitor, IPI-504, in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.11.131

21 January 2018

Identifiers

DOI

10.2217/NNM.11.131

1 reference

17 December 2017

PubMed ID

22339132

1 reference

17 December 2017